- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5383 - 1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
Patent holdings for IPC class A61K 31/5383
Total number of patents in this class: 1377
10-year publication summary
|
111
|
113
|
130
|
102
|
119
|
127
|
163
|
138
|
90
|
24
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Rigel Pharmaceuticals, Inc. | 613 |
57 |
| Shionogi & Co., Ltd. | 914 |
51 |
| F. Hoffmann-La Roche AG | 7958 |
30 |
| Novartis AG | 11238 |
27 |
| Genentech, Inc. | 3742 |
27 |
| Intra-Cellular Therapies, Inc. | 378 |
26 |
| Takeda Pharmaceutical Company Limited | 2961 |
19 |
| Daiichi Sankyo Company, Limited | 1829 |
17 |
| Bristol-myers Squibb Company | 5080 |
15 |
| Erasca, Inc. | 67 |
15 |
| Merck Sharp & Dohme LLC | 3689 |
15 |
| Gilead Sciences, Inc. | 1879 |
14 |
| KaNDy Therapeutics Limited | 19 |
14 |
| Boehringer Ingelheim International GmbH | 4629 |
13 |
| Hangzhou Innogate Pharma Co., Ltd. | 42 |
12 |
| Bow River LLC | 21 |
12 |
| Hoffmann-La Roche Inc. | 3060 |
11 |
| Corcept Therapeutics, Inc. | 284 |
11 |
| Insmed Incorporated | 207 |
11 |
| Sunshine Lake Pharma Co., Ltd. | 542 |
11 |
| Other owners | 969 |